Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265

Benzinga · 3d ago
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.